NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

The National Institutes of Health (NIH) is seeking applications for investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite. Applicants should be ready to initiate the clinical trial within the first quarter of the project period. Key aspects of the project include: • Support for phase I clinical trials for diagnostic and therapeutic interventions for HLBS disorders • Single or multisite trials • Project initiation within the first quarter of the project period • Establishment of regulatory approvals, drug supplies, and third-party agreements by the time of award • Award ceiling of $1,515,000